At the time of writing, Elanco Animal Health Inc [ELAN] stock is trading at $22.59, up 2.12%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ELAN shares have gain 4.39% over the last week, with a monthly amount glided 12.16%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on October 07, 2025, when JP Morgan upgraded its rating to a Overweight but kept the price target unchanged to $24 for it. Previously, Leerink Partners upgraded its rating to Outperform on July 17, 2025, and kept the price target unchanged to $18. On June 26, 2025, upgrade upgraded it’s rating to Outperform. UBS started tracking the stock assigning a Buy rating and suggested a price target of $18 on December 09, 2024. Leerink Partners initiated its recommendation with a Market Perform and recommended $14 as its price target on December 02, 2024. Morgan Stanley downgraded its rating to Equal-Weight for this stock on September 19, 2024, and downed its price target to $15. In a note dated January 05, 2024, Stifel upgraded a Buy rating on this stock and boosted its target price from $13 to $20.
For the past year, the stock price of Elanco Animal Health Inc fluctuated between $8.02 and $22.45. Currently, Wall Street analysts expect the stock to reach $22.25 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $22.59 at the most recent close of the market. An investor can expect a potential drop of -1.51% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
According to Elanco Animal Health Inc [NYSE:ELAN], the company’s sales were 4.48B for trailing twelve months, which represents an 4.81% jump. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.07 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.62.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.13 points at the first support level, and at 21.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.89, and for the 2nd resistance point, it is at 23.19.
Ratios To Look Out For
It is important to note that Elanco Animal Health Inc [NYSE:ELAN] has a current ratio of 2.60. As well, the Quick Ratio is 1.40, while the Cash Ratio is 0.39. Considering the valuation of this stock, the price to sales ratio is 2.50, the price to book ratio is 1.66 and price to earnings (TTM) ratio is 25.89.
Transactions by insiders
Recent insider trading involved Todd S and Jennifer G Young Li, Former CFO, that happened on Aug 11 ’25 when 49333.0 shares were purchased. Director, Kurzius Lawrence Erik completed a deal on Mar 07 ’25 to buy 10000.0 shares. Meanwhile, Director Kurzius Lawrence Erik bought 10000.0 shares on Mar 11 ’25.
